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Exosomes are extracellular vesicles of endocytic origin containing molecular signatures
implying the cell of origin; thus, they offer a unique opportunity to discover biomarkers
of disease. Plasmodium vivax, responsible for more than half of all malaria cases outside
Africa, is a major obstacle in the goal of malaria elimination due to the presence
of dormant liver stages (hypnozoites), which after the initial infection may reactivate
to cause disease. Hypnozoite infection is asymptomatic and there are currently no
diagnostic tools to detect their presence. The human liver-chimeric (FRG huHep)
mouse is a robust P. vivax infection model for exo-erythrocytic development of liver
stages, including hypnozoites. We studied the proteome of plasma-derived exosomes
isolated from P. vivax infected FRG huHep mice with the objective of identifying
liver-stage expressed parasite proteins indicative of infection. Proteomic analysis of
these exosomes showed the presence of 290 and 234 proteins from mouse and
human origin, respectively, including canonical exosomal markers. Human proteins
include proteins previously detected in liver-derived exosomes, highlighting the potential
of this chimeric mouse model to study plasma exosomes derived unequivocally from
human hepatocytes. Noticeably, we identified 17 parasite proteins including enzymes,
surface proteins, components of the endocytic pathway and translation machinery,
as well as uncharacterized proteins. Western blot analysis validated the presence of
human arginase-I and an uncharacterized P. vivax protein in plasma-derived exosomes.
This study represents a proof-of-principle that plasma-derived exosomes from P. vivax
infected FRG-huHep mice contain human hepatocyte and P. vivax proteins with the
potential to unveil biological features of liver infection and identify biomarkers of
hypnozoite infection.
Keywords: Plasmodium vivax, hypnozoite, exosome, proteomics, biomarker, humanized mice
Gualdrón-López et al. P. vivax Biomarkers in Liver-Humanized Mice
INTRODUCTION
Plasmodium vivax is a eukaryotic parasite that causes vivax
malaria, a disease previously considered to be a benign form
of malaria but now recognized to be associated with severe
disease and responsible for considerable morbidity and mortality
in endemic regions (Mueller et al., 2009; Kevin Baird, 2013).
This parasite is widely distributed in tropical and temperate
areas, including Ethiopia, Southeast Asia and South America,
where 8.5 million clinical cases occur each year, accounting for
more than half of all malaria cases outside Africa (World Health
Organization, 2017). In 2015, WHO proposed an ambitious
global goal that targets the control and elimination of malaria in
35 countries by the year 2030. In that sense, P. vivax represents
a major barrier to achieve this goal as this species evolved a
dormant form called a hypnozoite (Krotoski et al., 1982) that can
remain latent for weeks, months or even years in the liver after
the initial infection. Hypnozoites can reactivate and cause a blood
stage infection and symptoms, called a relapse, which also allows
for the possibility of transmission (Krotoski, 1985;Markus, 2011).
Importantly, relapses are responsible for the vast majority of
cases of vivax malaria in endemic countries where disease burden
specifically associated with relapses has been estimated (Betuela
et al., 2012; Nacher et al., 2013). Current diagnostic tools are
unable to detect asymptomatic patients harboring hypnozoites in
their liver, implying the existence of a large reservoir of parasites.
This is not only detrimental for people suffering the symptoms
of relapsing malaria, but represents a major obstacle toward
malaria elimination. Without a sensible diagnostic tool detecting
asymptomatic hypnozoites carriers, mosquitos feeding in these
individuals will continue to spread P. vivax.
The advances in humanized mouse models to study human
malaria infections have created opportunities to study host-
parasite interactions in vivo. More precisely, several humanized
mouse models with a human chimeric liver have been developed
(SCID Alb-uPA, FRG huHep, TkNOG, and the AFC8-hu
HSC/Hep) from which two of them (SCID Alb-uPA and FRG
huHep) have been successfully used to model extra-erythrocytic
infections in P. falciparum (Morosan et al., 2006; Vaughan et al.,
2012). An extended overview of humanizedmice models adapted
to malaria parasites have been reviewed previously (Kaushansky
et al., 2014). Importantly, a major breakthrough in the field
of P. vivax research was achieved by the development of the
FRG huHep chimeric mouse and its implementation as a robust
model for the development of pre-erythrocytic stages of P. vivax,
notably the growth and reactivation of hypnozoites. This model
allows research into the biological properties of this liver stage
and the use of the model to test the activity of potential radical
cure drugs (Mikolajczak et al., 2015).
Exosomes are 30–120 nm extracellular vesicles (EVs) of
endocytic origin secreted by eukaryotic cells and present in
virtually all-biological fluids (Yáñez-Mó et al., 2015). These
nanovesicles initially described in reticulocytes as a garbage
disposal mechanism during the terminal differentiation of
reticulocytes to erythrocytes (Pan and Johnstone, 1983) are
currently recognized by their remarkable role in intercellular
communication, and their potential as novel therapeutic agents
and biomarkers of disease (Théry et al., 2002; Gho and Lee,
2017). Exosomes are formed by invaginations of late endosomes,
a process that leads to the engulfment of cytoplasm and
specific molecular targets, forming vesicles contained inside
multivesicular bodies (MVB) that display lipids and proteins at
their external surface and enclose a unique luminal material.
These vesicles are released to the extracellular space after fusion
of MVB with the plasma membrane. Remarkably, the unique
properties of exosomes, including a great stability in circulation,
easy detection in complex biological fluids and a molecular
content that can be considered a “liquid biopsy,” support their
use as excellent biomarkers of disease (Simpson et al., 2009;
Revenfeld et al., 2014; Théry, 2015; Nedaeinia et al., 2016;
Bautista-López et al., 2017).
Importantly, exosomes and microvesicles have been reported
to be involved in intercellular communication, modulation of
the immune response, and in the regulation of vascular function
in malaria (Sampaio et al., 2017). A pioneer work, described
the presence of parasite proteins in exosomes isolated from
peripheral blood of P. yoelii infected mice (Martin-Jaular et al.,
2011). Later, other studies also showed that EVs secreted by
P. falciparum infected red blood cells (RBC) deliver DNA to
other infected cells promoting differentiation to sexual forms,
a step required for transmission to mosquitos (Regev-Rudzki
et al., 2013). In addition, EVs were also found capable of
communicating with host cells modulating the immune response
of macrophages and neutrophils (Mantel et al., 2013). In line with
these findings, is the recent report that showed the presence of
small RNA and genomic DNA of P. falciparum in exosome-like
vesicles involved in the activation of intracellular DNA sensors
in human monocytes (Sisquella et al., 2017). Furthermore, it
was reported that EVs derived from P. falciparum-infected RBCs
contain a functional RNA interference machinery that modulates
the expression of important genes in targeted endothelial
cells leading to alterations in the physiological properties
of endothelial tissue correlating with the pathophysiological
features of falciparum malaria (Mantel et al., 2016). In addition,
this regulation mechanism seems also to modulate parasites gene
expression in targeted infected cells (Wang et al., 2017). Together,
all these evidences support the role of EVs, including exosomes,
as important mediators of multiple functions in the context of
malaria infections. Importantly, all these studies has focus on
EVs secreted by blood stages forms of Plasmodium spp. parasites
while nothing is yet know regarding EVs secreted by liver stage
forms.
In this study, we have employed a proteomics approach to
explore the possibility of identifying parasite proteins from pre-
erythrocytic liver stages associated with exosomes secreted by
P. vivax infected FRG huHep mice; thus, opening the path for
searching for biomarkers of hypnozoite infection in this liver-
chimeric model.
METHODS
P. vivax FRG HuHep Mouse Infections
All animal procedures were conducted in accordance with
and approved by the Center for Infectious Disease Research
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Institutional Animal Care and Use Committee (IACUC). The
Center for Infectious Disease Research IACUC adheres to the
NIH Office of Laboratory Animal Welfare standards (OLAW
welfare assurance #A3640-01).
Mice were infected with P. vivax sporozoites as previously
described (Mikolajczak et al., 2015). The experimental design
was based in two settings: A first experimental infection (EI1)
was completed using six female FRG huHep mice by intravenous
injection of 1 million sporozoites. Infected mice were euthanized
8 days post infection (dpi), exsanguinated and livers harvested.
Four uninfected FRG huHep mice were used as controls.
The objective of this experimental infection was to compare
the proteomic composition of exosomes during two different
conditions (infection vs. non-infection). A second experimental
infection (EI2) was completed and female mice were euthanized
8 (n = 4), 10 (n = 4), 16 (n = 3), and 21 (n = 1) dpi (Figure S1).
Mice euthanized at day 10 received an intraperitoneal injection
of human reticulocytes as previously described (Mikolajczak
et al., 2015). This setting pursue to compare the proteome of
exosomes at different infection time-points in which different
liver-stage forms of P. vivax and exosomal cargo are expected.
Infections were verified either by fluorescence microscopy or
qRT-PCR. At each indicated dpi, livers were harvested and
immunofluorescence analysis was conducted to characterize
parasite liver burden by quantification of P. vivax liver schizonts
and hypnozoites (Data Sheet S1).
Blood Collection and Plasma Separation
Animals were euthanized and exsanguinated by cardiac
puncture. Whole blood from individual animals was collected in
tubes using a syringe preloaded with 0.1mL of 250U/mL heparin.
Samples were processed within 30min by centrifugation at 2,000
× g for 5min at 4◦C to remove platelets and platelet-derived
vesicles. Plasma samples were immediately transferred into a
clean tube and frozen at−80◦C.
Exosomes Purification
Exosomes were isolated from plasma samples of uninfected
and P. vivax infected FRG huHep mice by size-exclusion
chromatography (SEC) following our own standard
methodologies (de Menezes-Neto et al., 2015). Briefly, varying
aliquots of plasma (0.3–0.5mL) were thawed on ice and
processed by centrifugation at 2,000 x g for 10min at 4◦C. For
exosome purification, plasma collected from infected mice from
EI1 was processed individually. For mice in EI2, as plasma
volumes were <0.3mL, samples from 2 mice were pooled as
shown in Figure S1. Plasma supernatant was loaded on the
top of commercial qEV Sepharose 2B columns (10ml) (iZON
Sciences) pre-equilibrated with PBS. Fifteen fractions of 500 µl
were collected immediately after sample loading and analyzed
or frozen at −80◦C. Protein concentration was determined by
measuring absorbance at 280 nm with a Nanodrop (Thermo
Scientific, San Diego, CA).
Bead-Based Flow Cytometry
Phenotypic characterization of isolated exosomes was done by
detection of the exosomal marker CD5L in a bead-based flow
cytometry assay. This protein was found to be consistently
associated to plasma-derived exosomes in human samples (de
Menezes-Neto et al., 2015). Concisely, 50 µl of SEC fractions
was coupled to Aldehyde/Sulfate Latex Beads, 4% w/v, 4µm
(Invitrogen) by incubation for 15min with agitation. Coupled
beads were then blocked by incubation overnight with 1ml of
BCB Buffer [(PBS 1X/BSA 0.1% /NaN3 0.01% (both from Sigma-
Aldrich)] in a rotation device. Beads were further centrifuged at
2,000 x g for 10min, supernatant removed and pelleted beads
were re-suspended in 100 µl of BCB buffer. 45 µl of bead
suspension was incubated with anti-CD5L antibodies (Abcam:
ab45408) at 1/200 or IgG isotype control (Santa Cruz: SC-
3888) at 1/1000 for 30min at 4◦C in a round bottom plastic
microplate. Note that anti-CD5L recognize both mouse and
human CD5L antibody. After washing, samples were incubated
with a rabbit secondary-antibody conjugated to Alexa 488
(Invitrogen: A11008) at 1/1000 dilution for 30min at 4◦C
protected from light. After two wash steps, beads were re-
suspended in 100 µl of PBS and analyzed by flow cytometry
using a BD FACSVerse (BD Biosciences) machine. Median
Fluorescence Intensity (MFI) and bead count data were obtained
using FlowJo v.X Software (TreeStar). As control for specificity,
we have incubated SEC fraction 7 or 8 in the presence of a rabbit
isotype IgG antibody and secondary-antibody Alexa 488 (C1:
Exos+iso+2◦).
Nanoparticle Track Analysis
Size distribution and particle concentration was determined
by Nanoparticle Track Analysis (NTA) in a NanoSight LM10-
12 instrument (Malvern Instruments Ltd, Malvern, UK) as
previously reported in (de Menezes-Neto et al., 2015) using the
NTA software (version 3.2).
Cryo-Electronmicroscopy (cryo-EM)
SEC fractions containing high (F8) and low (F12) CD5L
MFI values were analyzed by cryo-EM to estimate size
and morphology of isolated vesicles as described elsewhere
(Montaner-Tarbes et al., 2016). Briefly, 10µl of SEC fractions was
diluted 1/5 in 0.22µm filtered PBS and laid on a Quantifoil R©
1.2/1.3 TEM grid, blotted to a thin film and plunged into
liquid ethane-N2(l) in the Leica EM CPC cryoworkstation (Leica,
Wetzlar, Germany). Grids were transferred to a 626 Gatan
cryoholder and maintained at −179◦C. Samples were analyzed
with a Jeol JEM 2011 transmission electron microscope (Jeol,
Tokyo, Japan) at an accelerating voltage of 200 kV. Images
were recorded on a Gatan Ultrascan 2000 cooled charge-
coupled device (CCD) camera with the Digital Micrograph
software package (Gatan, Pleasanton, CA). Vesicle diameter was
quantified using ImageJ (NIH) where pixels were calibrated to
nanometers.
Cloning, Expression and Purification of
Recombinant Truncated PVX110940
The protein sequence of PVX110940 was retrieved from
Plasmodium Genomic Database (PlasmoDB) (http://plasmodb.
org/). B-cell linear epitopes prediction was done using the
Bebipred algorithm (Jespersen et al., 2017) in the portal of
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Immune Epitope Database and Analysis Resource [(IEDB)
http://www.iedb.org/]. Based on Bebipred score, a region of 407
aa corresponding to amino acids 261 and 667 was amplified
from genomic DNA of the P. vivax Sal-I strain using the
primers: PVX110940-Tr-F: 5′-TAAGAATGCGGCCGCGAGG
ATGTGCTGCCAAGTGT-3′ and PVX110940-Tr-R: 5′-
TTACTCGAGTCATTCATCCTCCGCTTCATCCTC-3′. PCR
amplified fragment was digested with NotI and XhoI (Thermo
scientific) and directly ligated into the pIVEX1.4-GST vector
from which N-terminal GST-tagged fusion proteins are
expressed (Rui et al., 2011). After cloning, the construct was
analyzed by DNA sequencing. GST-PV110940-tr in vitro protein
expression was done in a commercial wheat germ cell-free
system (Biotechrabbit) accordingly to manufactures instructions.
Briefly, 4 µg of plasmidic DNA from two positive clones was
used as a template in 50 µl of in vitro transcription/translation
reaction. GST-PVX110940-Tr recombinant protein was purified
by affinity chromatography on GST spin trap columns (GE
healthcare) and eluted with 10mM glutathione in 50mM Tris-
HCl pH 8.0. Purified protein was desalted against sterile PBS in
a 10 kDa Amicon devise (Millipore). Bradford assay (Biorad)
was used to quantify protein concentration. Protein production
was confirmed by SDS-PAGE and western blot analysis using
anti-GST primary antibody (1/5000) (Invitrogen: A5800) and
680LT fluorescent conjugated rabbit secondary antibody (Licor
92568021) (Li-Cor Biosciences, Lincoln, NE, USA)].
Polyclonal Antibodies Generation
The immunization procedure was approved by the Animal
Experimentation Ethics Committee of the “Hospital Universitari
Germans Trias I Pujol” under the protocol number DAAM907.
Two 6-week-old female BALB/c mice were immunized by
subcutaneous injection using 10 µg of purified recombinant
GST-PVX110940-Tr in combination with aluminum hydroxide.
Two consecutive boosts were done at intervals of 21 days
after which animals were euthanized and bled by cardiac
puncture. Blood was incubated during 2 h at RT to promote
coagulation and subsequently sera were collected from the
supernatant. Immunoreactivity was evaluated against purified
GST-PVX110940-tr recombinant protein by western blotting.
Western Blot Analysis
Protein samples were heated at 95◦C for 5min and separated on
a 10–12% SDS-PAGE, transferred on to Hybond-C nitrocellulose
membrane (Amersham) and blocked in blocking buffer (1 X
PBS, 0.1% Tween-20, 5% milk powder) overnight. After washes,
blots were incubated for 1 h with primary antibodies [rabbit anti-
GST (1:5000, Invitrogen: A5800), mouse anti-GST-PVX110940-
Tr (1/500 or 1/50), rabbit anti-arginase I (1/1000) (Genentex:
GTX109242)] in antibodies buffer (1X PBS, 0.1% Tween-20,
1% milk powder). Subsequently, the blots were washed and
incubated for 1 h with the Li-Cor IRDye-labeled secondary
antibodies IRDye 680RD goat anti-rabbit (925-68021) (1/20.000)
and IRDye 800CW goat anti-mouse (925-32210) (1/15.000)
(Li-Cor Biosciences, Lincoln, NE, USA). Blots were scanned
and analyzed with the Odyssey quantitative western blot near-
infrared system (Li-Cor Biosciences, Lincoln, NE, USA) using
default settings, with the exception of 700-laser intensity, which
was set up at 3.
Exosome Solubilization and Protein
Digestion for LC-MS/MS
Hundred micro liters of SEC fractions F7, F8, F9, F10 were
pooled and designated as exosomal-enriched fractions (ExEFs).
Similarly, 100 µl of SEC fractions F5, F6, F11, F12 were pooled
and designated as microvesicles-enriched fraction (MvEF). ExEF
and MvEF were mixed with equal volume of RIPA buffer
[50mM Tris pH 8, 150mM NaCl, 1mM EDTA, 0.5 % NP-
40, 10mM MgCl2, 0.5mM DTT, 1:100 protease inhibitors
(Thermo Scientific)], incubated at 70◦C and further sonicated
for 10min with cycles of 30 s at the highest intensity (Bioruptor-
Diagenode) to ensure exosomal membrane disruption. Samples
were centrifuged at 16,000 x g during 15min at 4◦C and
supernatant recovered. Proteins were then precipitated with
cold acetone [1/6 ratio (v/v)] O/N at −20◦C and recovered
after subsequent centrifugation at 16,000 x g during 15min
at 4◦C. Precipitated proteins were resuspended in 30 µl 6M
urea and further reduced in 10mM dithiothreitol (DTT; Sigma)
for 1 h at 37◦C and alkylated with 55mM of iodoacetoamine
(IAM, Sigma) during 30min at RT. Samples were brought to
2M urea and digested with a concentration of Lys-C (Wako)
corresponding to 10% (µg) of the digested sample, overnight
at 37◦C. Subsequently, samples were further diluted to 1M urea
and digested for 12 h with a concentration of trypsine (Promega)
corresponding to 10% (µg) of the digested sample. Finally,
samples were desalted on MicroSpin C18 columns (The Nest
Group), evaporated to dryness and dissolved in 0.1% formic acid.
Mass Spectrometry
Approximately 1 µg of each sample was analyzed using liquid
chromatography (nanoLCULTRA-EKSIGENT) followed bymass
spectrometry on a 90min gradient in the Orbitrap Fusion
Lumos (Thermo Fisher Scientific). As a quality control, BSA
controls were digested in parallel and ran between each sample
to avoid carryover and assess the instrument performance. The
Mass spectrometry proteomic data have been deposited to the
ProteomeXchange Consortium via PRIDE (Vizcaíno et al., 2016)
partner repository with an dataset identifier PXD008945.
Protein Identification
Raw data files were analyzed with the search algorithm
Mascot v2.5.1 (http://www.matrixscience.com) on the Proteome
DiscovererTM Software V2.0 (Thermo Scientific) using three
protein databases: UniProt P. vivax (31,374 entries), UniProt
human (20,133 entries) and UniProt mouse databases (16,832
entries), downloaded on April 28th, 2017. Peptides have been
filtered based on: (i) minimum peptide length of 7; (ii) maximum
false discovery rate (FDR) for peptides and proteins of 1%;
(iii) minimum peptides per protein of 1 and minimum unique
peptides per protein of 1; (iv) minimum score for modified
peptides was set to 40; (v) main search error of 4 ppm.Mouse and
human proteins were accepted if more than 2 unique peptides
were identified with a false discovery rate < 1% and assigned
with the category of Master protein by Proteome DiscovererTM
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software. In the case of proteins identified by 1 unique peptide,
a criterion of its presence in at least 2 samples was applied.
Assigned contaminants, keratins and abundant proteins plasma
reported in (deMenezes-Neto et al., 2015) were removed. Human
and mouse proteins were compared to the public extracellular
vesicle Vesiclepedia protein database (http://www.microvesicles.
org/) and intersections were represented in the FunRich Software
(Pathan et al., 2015). For P. vivax protein identification, a
different criterion was applied, accepting proteins identified with
1 unique peptide, FDR < 1%, category of Master Protein by
Proteome Discoverer software after confirming individual high
quality spectrum. P. vivax proteins UniProt entries were used
to retrieve protein sequences and blasted to the PlasmoDB
against P. vivax proteins in order to identify and assign the
corresponding gene name in the SalI and P01 strains. Redundant
entries were filtered out from the final list of proteins.
Gene ontology enrichment of human proteins for all
categories was done with the Database for Annotation,
Visualization, and Integrated Discovery (David 6.8) (Huang et al.,
2009).
Statistical Analysis
Protein abundance data was estimated from the average peak area
of the three top peptides detected by Proteome DiscovererTM
Software v2.0 (Thermo Scientific). Briefly, data were normalized
using quantile normalization. Then, data were log2-transformed
to hold normality assumption that is required in downstream
analyses. Statistical analyses in both comparisons Infected vs.
Control and ExEF vs. MvEF was performed by using lineal
or censored regression models. Censored data appear in those
samples having average peak area values below 105 correspond
to values not detected. Protein data were analyzed using linear
models implemented in limma Bioconductor package (Ritchie
et al., 2015). Those proteins having censored data in <50% of
samples were analyzed using censored regression, implemented
in censreg R package (Henningsen et al., 2017), as proposed here
(Helsel, 2005).
RESULTS
Isolation of Plasma-Derived Exosomes
From Human Liver-Chimeric FRG huHep
Mice
To initially explore the protein content of plasma-derived
exosomes in FRG huHep mice during P. vivax infection, we
analyzed individual plasma samples from two groups of mice:
a control group corresponding to uninfected mice and a group
of infected mice euthanized 8 dpi (EI1). Further, and taking
into account the liver infection kinetics previously established
by Mikolajczak et al. (2015), we analyzed plasma samples of
P. vivax infected mice after 8, 10, 16, and 21 dpi in order
to get insight into possible changes in the protein content
of plasma-derived exosomes associated with the infection by
specific parasite liver stages (EI2). Plasma samples from both
experiments were processed for exosome isolation by SEC. SEC
fractions were evaluated in a bead-based flow cytometry assay
for the detection of CD5L, an exosomal marker identified in
MS studies of exosomes isolated from plasma (de Menezes-
Neto et al., 2015). The distribution of CD5L signal throughout
SEC fractions showed a standard and reproducible profile with
the majority of exosomes eluting between fractions 7 and 10,
constituting the exosome-enriched fractions (ExEFs) (Figure 1A
and Figures S2A,B). Similar results were obtained with CD9 and
CD81, other exosomal markers (data not shown). To further
characterize the isolated exosomes in the ExEFs, we performed
NTA of individual and pooled fractions 7–10 to determine the
size and concentration of particles within these fractions and
conducted cryo-electronmicroscopy (Cryo-TEM) specifically of
fraction 8 (F8) to characterize vesicle size and morphology.
Moreover, for comparative purposes, we also performed Cryo-
TEM of F12, enriched in microvesicles and soluble proteins
(MvEF). NTA showed vesicles with a mode diameter of 117 nm
and a concentration of 2.67 x 1011 particles/ml (Figure 1B).
Cryo-TEM demonstrated highly pure, round vesicles free of
protein aggregate clumps and 42% of vesicles in F8 were between
50 and 100 nm in diameter (Figure 1C and data not shown). In
contrast, an aggregated and complex material was observed in
SEC distal fraction 12 where microvesicles, other particles and
soluble plasma proteins are expected (Figure 1C).
Proteomic Analysis of Plasma-Derived
Exosomes From P. vivax Infected FRG
huHep Mice: The Human Component
We determined the proteome of ExEFs and searched for peptide
spectrum matches against human, mouse and P. vivax protein
databases. Data from EI1 and EI2 identified 234 human proteins,
290 mouse proteins and 17 P. vivax proteins (Data Sheet S2)
collectively. To further demonstrate the ExEFs were mostly
depleted of abundant contaminating plasma proteins, thus
avoiding this major confounder in MS analysis, we performed a
statistical comparison of the human identified proteins enriched
in the ExEFs and those enriched in the MvEF from EI1,
using a statistical method based on censured and lineal data
(Helsel, 2011; Henningsen et al., 2017). We have centered our
statistical analysis in samples from EI1 because the number of
replicate samples in this setting give us sufficient statistical power
to perform a robust comparison. As shown in Figure 2 and
Data Sheet S3, most plasma proteins were significantly depleted
in ExEFs, as estimated from the fold change of the average peak
area of the 3 top peptides for each identified protein in the ExEF
compared to the MvEF. Altogether, these results strongly suggest
that plasma-derived exosomes from P. vivax infected FRG huHep
mice are efficiently isolated by SEC and that abundant plasma
proteins, a large confounding effect in MS analysis (de Menezes-
Neto et al., 2015), were largely depleted by this single-standing
methodology.
Because human hepatocytes are the only human cells present
in these chimeric mice, we initially analyzed the protein content
of human hepatocyte-derived exosomes. Global comparison of
the human proteins identified compared with proteins listed in
Vesiclepedia, a public repository of extracellular vesicle proteins,
showed that 96% of human proteins associated with exosomes
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FIGURE 1 | Exosomes purification and characterization. (A) SEC fractions of plasma-derived exosomes from P. vivax infected FRG huHep mice from EI1 and EI2
were analyzed in a flow cytometry bead-based assay for the presence of exosomal marker CD5L. Mean fluorescence intensity (MFI) of anti-CD5L and control
antibodies (rabbit-isotype) as well as protein concentration was assayed for each fraction and a representative analysis for a single sample is shown. (B) NTA profile
(size [nm] vs. concentration [particles/ml]) of the fraction with the highest CD5L MFI (F8) shows enrichment in nanoparticles around 120 nm. (C) Cryo-EM of F8
confirms the presence of abundant, round nanovesicles measuring 100–150 nm. SEC fraction 12 (F12) identified aggregates and nanovesicles of diverse sizes.
in this mouse model have been previously reported as associated
with extracellular vesicles (Figure 3A), including classical
exosomal markers such as clathrin heavy chain 1, annexin A2,
glyceraldehyde-3-phosphate dehydrogenase, moesin, and Ras-
related Rap-1b-like proteins. Next, subcellular localization of
the identified human proteins was assigned based on GO terms
retrieved from UniProt and the frequency of proteins found
in each subcellular compartment. This analysis showed that a
considerable percentage corresponds to the extracellular region
(33%), while the two other more abundant compartments were
the plasma membrane and cytosol (Figure 3B). To gain insight
into the function of the human proteins, a GO enrichment
analysis was performed (Figure 3C and Data Sheet S4). As
expected, the Cellular component category showed a significant
enrichment of proteins associated with extracellular exosomes
and blood microparticles. The Biological processes category
showed enrichment of proteins involved in the negative
regulation of endopeptidase activity and platelet degranulation
whereas Molecular function was enriched for endopeptidase
activities and its inhibition.
Several proteomes of hepatocyte-derived exosomes has been
previously published (Conde-Vancells et al., 2008; Zhao et al.,
2014; Jia et al., 2017). These studies have employed in vitro
cultured rat hepatocytes and the immortalized hepatocytes
HepAD38 and Huh7 cell lines as sources of exosomes isolated
from the culture supernatant. In order to explore the correlation
between our data and that of those publications, we compared the
human proteins associated with exosomes in the P. vivax infected
and uninfected FRG huHepmice with these previously published
proteomes. Importantly, 106 out of 234 proteins identified in our
study (45%), have been previously reported in at least 1 proteome
whereas 128 (55%) were newly identified liver-exosome cargo
proteins. As expected from the different isolation methods and
analysis, a different number of common proteins was found
on individual comparisons of each report with our data set
(Data Sheet S5).
In order to identify human liver proteins associated with
exosomes during P. vivax infection, we performed a statistical
comparison of human proteins identified in infected animals
versus uninfected control mice. This analysis showed that several
proteins identified in the ExEFs were differentially associated
with P. vivax infections (P-value < 0.05). We classified the
samples in a dendogram taking into account the significant
proteins expression values from the comparison infected vs.
uninfected in FRG huHep mice. The dendogram separated
the samples according to infection (IM; CM) although some
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FIGURE 2 | Exosome-enriched fractions (ExEFs) are depleted of contaminating plasma proteins. The log fold-change (FC) in abundance of human proteins detected
by LC-MS/MS in the ExEFs and MvEFs of P. vivax infected FRG huHep mice from EI1 were compared. The horizontal line represents p = 0.01 and vertical lines
correspond to a 3-log fold increase or decrease in abundance. Green points represent p > 0.01 & FC between [−3,3], blue points represent p < 0.01 and red points
represent p > 0.01 & FC >3 or FC< −3. Proteins with p < 0.01 and FC>3 or FC<-3 are labeled. Supporting data are shown in Data Sheet S3.
variability was present (Figure 4A and Data Sheet S3). The list
of proteins used for the dendogram is detailed in the Figure 4B.
The table informs not only about the protein but also about
the p-value (corrected by FDR) and fold change obtained in
the comparison. Interestingly, when we compared these proteins
to a recently published proteome of total plasma proteins from
P. vivax patients (Ray et al., 2016), we found that 19 out of
23 of the statistically significant human proteins associated with
P. vivax infection in the mice were also present in the plasma
of P. vivax infected patients (Figure 4B, bold). These results
indicate that P. vivax infection in FRG huHep mice recreates the
dynamic changes that occur in the plasma protein content during
natural P. vivax infections in human.
Proteomic Analysis of Plasma-Derived
Exosomes From P. vivax Infected FRG
huHep Mice: the Parasite Component
MS analysis revealed the presence of 17 P. vivax proteins
in ExEFs (Table 1). Importantly, this dataset excluded false
positive P. vivax proteins identified in identical peptide
spectrum matches of ExEFs from uninfected FRG huHep
mice. Among the identified proteins we found a putative
chaperon HSP70 (PVX_099315), the merozoite surface
protein MSP3.1 (PVX_097670), proteins involved in DNA
replication, chromatin structure and ribosome biogenesis
[DNA helicase (PVX_099345), Histone H2A (PVX_095190),
and 50S ribosomal L24 (PVX_123825)]; the putative
enzymes methyltransferase (PVX_000890), diacylglycerol
kinase (PVX_116900) and carbamoyl phosphate synthetase
(PVX_122240); a putative protein from the parasite endocytic
pathway: clathrin coat assembly protein AP50 (PVX_118455),
two integral membrane proteins identified as a putative
potassium channel (PVX_123990) and a putative member of
the mitochondrial carrier protein family (PVX_115395); as well
as five uncharacterized hypothetical proteins (PVX_090185,
PVX_110940, PVX_115100, PVX_119280, PVX_080600) and a
putative “moonlight” oocyst capsule protein (PVX_095215).
We compared the distribution of these proteins at the
different infection time points, with the objective of identifying
parasite proteins secreted from infected cells that could be
associated with a specific P. vivax liver stage. Interestingly,
we found two proteins present at all infection time points:
heat shock protein 70 (PVX_099315) and the putative histone
H2A (PVX_095190) while the majority of the proteins showed
a variable distribution (Table 1). Some proteins were detected
at specific time points, notably three proteins (PVX_118455,
PVX_119280, PVX_122240) were uniquely present in the ExEFs
from day 16 and 21 post-infection. At these time points during
infection the majority of replicating schizonts present in the liver
have egressed and the remaining parasites are non-replicating
hypnozoites. Because liver schizonts at day 8 contain tens of
thousands of merozoites, the hypnozoite signal is easily muted
in these samples.
In order to maximize the possibility of identifying other
P. vivax proteins secreted either as soluble factors or associated
with other subtypes of extracellular vesicles, we also included
in our analysis the MvEFs. Interestingly, we identified peptides
corresponding to 20 parasite proteins (Table 2). These included
several putative membrane associated proteins from the PIR
multigene family [variable surface protein Vir12 (PVX_106220),
an unspecified product orthologue to a PIR protein of strain
PVP01 (PVX_241290), VIR protein (PVX_101503) and a
variable surface protein Vir9-related (PVX_096935)]; two
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FIGURE 3 | Human Proteome of FRG huHep plasma-derived exosomes. (A) Global analysis of all human proteins identified in EI1 and EI2 shows that of the 234
human proteins identified in the ExEFs from uninfected and P. vivax infected FRG huHep mice, 224 are reported in Vesiclepedia, a Web-Based repository of
extracellular vesicle cargo proteins. (B) Subcellular localization distribution of 234 human proteins groups identified in plasma derived-exosomes from uninfected and
P. vivax infected mice. Subcellular compartment was assigned based on GO terms in the UniProt database. (C) Functional enrichment analysis of the top ten more
significant Gene ontology (GO) terms of human proteins group enriched in exosomes derived from plasma of uninfected and P. vivax infected FRG huHep mice
(P-value 0.001). Bar plot shows biological process, cellular component, and molecular function GO categories.
isoforms of the Merozoite surface protein 3 family [MSP3.5
(PVX_097690) and MSP3.10 (PVX_097720)]; a putative
reticulocyte binding protein 1b (PVX_098582), a putative
THO complex subunit 2 (PVX_101385), a protein involved
in transcription/export of mRNAs; putative enzymes like the
ATP-dependent acyl-CoA synthetase (PVX_002785) and M18
aspartyl aminopeptidase (PVX_087090); a member of the
ribosomal 26S complex [26 complex proteasome regulatory
subunit p55, putative (PVX_001760)] and 9 hypothetical
proteins of unknown function (PVX_111420, PVX_089245,
PVX_087720, PVX_092720, PVX_090990, PVX_082938,
PVX_124005, PVX_095185, PVX_117060).
Validation of Detected Human and Parasite
Proteins
We identified in the ExEFs the human enzyme arginase I
(Data Sheet S2), a liver protein that converts L-arginine into
ornithine, a reaction involved in the polyamine synthesis
pathway and in the regulation of nitric oxide metabolism. We
got an interest in this enzyme because it was found to be
associated to the external side of hepatocyte-derived exosomes
from rat origin where it is involved in blood metabolome
remodeling and in modulation of endothelium function (Royo
et al., 2017) and therefore could be an interesting exosomal
protein for validation. Western blot analysis, using a commercial
anti-arginase I antibody, validated the presence of this enzyme
in exosomal preparations from P. vivax infected and uninfected
FRG huHep mice (Figures 5A,B). Surprisingly, we detected a
band migrating as a protein with an apparent molecular weight
of 59 kDa, suggesting an increase of 20 kDa with regard to
its predicted molecular weight. Whether this increase is due to
a posttranslational modification, caused by the interaction of
arginase I with exosomes, is currently under study. Interestingly,
we were able to detect in a flow cytometry bead-based assay,
an arginase I positive signal in SEC fractions of plasma samples
obtained from a P. vivax infected patient. The profile followed
the signal of the exosomal marker CD5L (Figure 5C), suggesting
the presence of an arginase I positive exosome population in the
plasma of infected patients.
To validate the presence of parasite proteins in plasma-
derived exosomes of P. vivax infected FRG huHep mice,
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FIGURE 4 | Comparison of human liver proteins from P. vivax infected FRG KO huHep mice with plasma proteins from patients in natural infections. (A) Dendogram
depicting the results of a statistical comparison (supervised and lineal methods) between the human proteins identified by LC-MS/MS-based proteomics in enriched
exosomes derived from plasma of P. vivax infected and uninfected FRG huHep mice from EI1. IM-1 to IM-6 (Infected mice), CM-1 to CM-4 (uninfected mice).
Supporting data are shown in Data Sheet 3. (B) Twenty-three human proteins found to be significantly over-represented in infected FRG KO huHep mice (P-value <
0.05, FDR adjusted) were compared with the proteome of total plasma proteins from P. vivax patients (Ray et al., 2016). Nineteen proteins (in bold) were detected in
both datasets.
we decided to target the parasite protein identified with the
highest number of unique peptides in the ExEFs, PVX_110940.
It corresponds to a hypothetical conserved protein of 84
kDa with orthologues in P. cynomolgi, P. knowlesi, P. fragile,
and P. inui and with a predicted signal peptide at its N-
terminal end (Figure 6A). Of interest, this gene is located at
exactly the same genomic locus as the P. falciparum liver
stage antigen 1; yet, sequence similarity analysis precluded to
include the falciparum gene as truly syntenic. We amplified
a fragment of PVX_110940 corresponding to an antigenic
region predicted to be a linear epitope of B-cells (Figure 6A)
and cloned it using the expression vector pIVEX-GST (Rui
et al., 2011). After in vitro transcription/translation, a GST-
recombinant protein containing a truncated 17 kDa region
of the predicted B-cell epitope was purified and shown to
specifically react with an anti-GST antibody by western blot
analysis (Figure 6B). The purified recombinant protein was used
to raise polyclonal antibodies inmice.Western blot analysis using
these antibodies demonstrated that this antiserum efficiently
recognized the purified recombinant protein (Figure 6C), as well
as ExEFs both, in cytometry bead-based assays and western
blot (Figures 6D,E respectively). These complementary results
indicates the presence of PVX110940 in several samples, notably
sample 101 from EI2, where the proteomic analysis identified the
protein with 3 unique peptides. All together, these data show that
plasma-derived exosomes isolated from P. vivax infected FRG
HuHep mice contain parasite proteins.
DISCUSSION
Here, we present the first mass spectrometry (MS)-based
proteomics analysis of plasma-derived exosomes from a human
liver-chimeric mouse infected with pre-erythrocytic stages,
including hypnozoites, of P. vivax. Since the discovery of
hypnozoites (Krotoski et al., 1982), little progress has been made
to decipher biological aspects of this parasite liver stage and
the nature of its latency. This is due to the obvious limitations
imposed by the inaccessibility to study liver samples from
P. vivax patients. However, progress has been achieved since
the implementation of in vitro cultures of P. cynomolgi in
non-human primate hepatocytes, a relapsing monkey parasite
(Dembélé et al., 2014) and P. vivax in human hepatocytes
(Sattabongkot et al., 2006; Chattopadhyay et al., 2010; Ng et al.,
2015), successfully showing the development and reactivation
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TABLE 1 | P. vivax proteins identified in plasma-derived exosomes from FRG huHep infected mice.
Protein UniProt AC PlasmoDB entry Experimental infection Detection
D8 D10 D16 D21
ATP-dependent DNA helicase Q1, putative A5K6Q0 PVX_099345 EI1 *
Methyltransferase, putative A0A0J9SJ43 PVX_000890 EI1 *
Mitochondrial carrier protein, putative A0A0J9TA28 PVX_115395 EI1
Hypothetical protein, conserved A0A0J9U1I1 PVX_090185 EI1 *
Merozoite surface protein 3 (MSP3.1) A0A0J9V216 PVX_097670 EI1 *
Heat shock protein 70, putative A0A0J9TFN8 PVX_099315 EI2 * * *
Hypothetical protein, conserved A5KDU3 PVX_110940 EI2
Histone H2A, putative A0A0J9TEH1 PVX_095190 EI2 *
Potassium channel, putative A5K072 PVX_123990 EI2 *
Diacylglycerol kinase, putative A0A0J9VER0 PVX_116900 EI2 *
Hypothetical protein, conserved A0A0J9TSI7 PVX_115100 EI2
Clathrin coat assembly protein AP50, putative A5K403 PVX_118455 EI2
Hypothetical protein, conserved A0A0J9SCT6 PVX_119280 EI2
Carbamoyl phosphate synthetase, putative A0A0J9SP67 PVX_122240 EI2
Oocyst capsule protein, putative A0A0J9SW43 PVX_095215 EI2
Hypothetical protein, conserved A0A0J9SBG1 PVX_080600 EI2
50S ribosomal protein L24, putative A0A0J9TNT0 PVX_123825 EI2 *
17 P. vivax proteins were identified in the exosome-enriched SEC fractions (ExEF) of infected FRG huHep mice. Proteins identified in the samples from experimental infection 1 and 2
are depicted. Gray boxes indicate protein presence. *Proteins also identified in the microvesicle-enriched SEC fractions (MvEF—Table 2) at the indicated days post infection. Of note,
high quality spectrum of individual peptides were manually inspected. Extended mass spectrometry data is found in the Data Sheet S2.
TABLE 2 | Plasmodium vivax proteins identified in the microvesicles-enriched SEC fractions (MvEF) of plasma-derived exosomes from FRG huHep infected mice.
Protein UniProt AC PlasmoDB entry Experimental infection Detection
D8 D10 D16 D21
Variable surface protein Vir12, putative A0A0J9U104 PVX_106220 EI1
Hypothetical protein A5KE32 PVX_111420 EI1
Hypothetical protein, conserved A0A0J9SJ40 PVX_089245 EI1
Reticulocyte binding protein 1b A0A0J9SH34 PVX_098582 EI1
Hypothetical protein, conserved A5KA42 PVX_087720 EI1/EI2
Hypothetical protein, conserved A0A0J9TD53 PVX_092720 EI1/EI2
THO complex subunit 2, putative A0A0J9S679 PVX_101385 EI1
Hypothetical protein, conserved A0A0J9SCY7 PVX_090990 EI1/EI2
Hypothetical protein, conserved A0A0J9SQK8 PVX_082938 EI1
Hypothetical protein, conserved A0A0J9SNU2 PVX_124005 EI2
ATP-dependent acyl-CoA synthetase, putative A0A0J9T1B9 PVX_002785 EI2
M18 aspartyl aminopeptidase, putative A0A0J9TXR1 PVX_087090 EI2
Merozoite surface protein 3 (MSP3.5) A0A0J9U2T8 PVX_097690 EI2
PIR protein_unspecified product A0A0J9TLW5 PVX_241290 EI2
26S proteasome regulatory subunit p55, putative A0A0J9SG98 PVX_001760 EI2
Hypothetical protein, conserved A0A0J9SW37 PVX_095185 EI2
Hypothetical protein, conserved A5K376 PVX_117060 EI2
Merozoite surface protein 3 (MSP3.10) A0A0J9SAF3 PVX_097720 EI2
PIR protein_variable surface protein Vir9-related A0A0J9SF54 PVX_096935 EI2
PIR protein_ VIR protein A0A0J9T8Z3 PVX_101503 EI2
20 P. vivax proteins were identified in the MvEFs of infected FRG huHep mice. Proteins identified in the samples from experimental infection 1 and 2 are depicted. Gray boxes indicate
protein presence at the indicated days post infection. Of note, high quality spectrum of individual peptides were manually inspected. Extended mass spectrometry data is found in the
Data Sheet S2.
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FIGURE 5 | Validation of arginase I as an exosomal-associated protein. (A) Commercial anti-arginase I antibodies were used to analyze the presence of arginase I in
SEC fraction 11 from P. vivax infected at 8 and 16 dpi (EI1: D86 and EI2: D162) and uninfected (NI) FRG huHep mice. These samples correspond to mice where
arginase I was identified by LC-MS/MS. An equal volume of each fraction was loaded on the gel. Ten micro grams of liver extract from mouse and human were used
as positive controls. (B) Western blot analysis of ExEFs purified from P. vivax infected FRG huHep mice from EI2 on days 8, 10, 16, and 21 post-infection. An equal
volume of CD5L-highest fraction was loaded on the gel. (C) Flow cytometry bead-based assay showing arginase I detection in exosomal fractions isolated from
plasma of a P. vivax patient. This sample correspond to an unidentified stored plasma of the biobank from the FMT-HVD. Mean fluorescence intensity (MFI) of
anti-arginase and control antibodies (rabbit-isotype) was assayed for each fraction. CD5L was used as plasma exosomal marker.
of hypnozoites. These systems are currently being used in
transcriptomic studies (Cubi et al., 2017) and hypnozoite-specific
drug screening platforms. The recent report of an in vivo mouse
model where pre-erythrocytic liver stages of P vivax can develop
and progress to the blood stages, represents an unprecedented
opportunity to explore the possibilities of identification of a
biomarker of liver stages, notably hypnozoites.
The recent expansion of research in the EV, including
exosome, field has put in the spotlight the potential of these
vesicles as biomarkers in a large variety of diseases, ranging from
infectious diseases, neurodegenerative disorders, and diabetes,
to different types of cancer (Simpson et al., 2009; Melo et al.,
2015; Thompson et al., 2016; Bautista-López et al., 2017; Garcia-
Contreras et al., 2017). Exosomes present in biological fluids
are currently being profiled to detect not only particular disease
biomarkers, but also molecules that are prognostic of the
response to drug treatment and the evolution of some diseases
(Simpson et al., 2009).
In this work, we have shown that human hepatocytes
engrafted in the liver of chimeric FRG huHep mice represent
an appropriate system to obtain hepatocyte derived-exosomes
secreted in the bloodstream. The purification approach
based on SEC, enabled us to obtain purified exosomes-like
vesicles, as was demonstrated by their molecular and structural
characterization (Figures 1A,C). Moreover, we could statistically
show the depletion of a high number of abundant plasma
proteins from ExEFs and the respective enrichment of proteins
previously detected in exosomes (Figure 2). Thus, size-exclusion
chromatography, as shown elsewhere (de Menezes-Neto et al.,
2015), offers a single-standing methodology for isolation
and MS characterization of proteins mainly associated with
plasma-derived exosomes.
P. vivax infection causes alterations in the plasma/serum
protein profile as was recently demonstrated in a quantitative
proteomic analysis of P. vivax patients (Ray et al., 2016). The
authors claimed that these changes reflect the pathophysiological
changes that occur in the human host during the different stages
of vivax malaria infection. Our results indicate that the in vivo
model of FRG huHep mice recreates those changes as 83% of the
human proteins found to be significantly expressed in infected
FRG huHep mice (Figure 4) were found to be altered in the
plasma of patients during natural infection. Importantly, these
also indicate that in natural infection, the liver secretes exosomes
with this protein cargo.
Among the identified hepatocyte-exosomal proteins, we
found arginase I, a cytosolic enzyme that is mainly synthesized
in liver cells and that catalyzes the last step of the urea
cycle, converting the amino acid arginine into L-ornithine.
This enzymatic reaction also provides the initial substrate to
polyamine biosynthesis, a pathway proved to be essential for
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FIGURE 6 | Validation of PVX110940 in plasma-derived exosomes from P. vivax infected FRG huHep mice. (A) Schematic representation of full-length PVX110940
protein and a recombinant GST-fusion truncated (GST-PVX110940-Tr) version containing a predicted B-cell antigenic region of 156 amino acids. Red square
represents a predicted N-terminal signal peptide. (B) GST-PV110940-Tr was produced from two E. coli clones (C11 and C25) in a wheat germ cell-free system and
(Continued)
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FIGURE 6 | affinity-purified products resolved on SDS-PAGE. Western blot analysis using monoclonal anti-GST antibodies. (C) Recombinant GST-PVX110940-Tr was
used to immunize mice and produce polyclonal antibodies. Western blot analysis shows recognition of GST-PVX110940-Tr purified recombinant protein and purified
GST. (D) Flow cytometry bead-based assay showing PVX110940 detection in ExEF from plasma of P. vivax infected FRG huHep mice from EI1 and EI2. Beads were
incubated with the highest-CD5L SEC fraction of each sample and used for detection of PVX110940 using the polyclonal antibodies raised in mice. Mean
fluorescence intensity (MFI) of PVX110940 and controls was assayed. Specificity controls were as follows: C1: Highest-CD5L SEC fraction of each sample incubated
with Alexa-488 mouse secondary antibody. C2: Pool of CD5L highest fraction of all samples incubated with isotype rabbit antibody and Alexa-488 mouse secondary
antibody. Stars indicate the samples were positive detection was observed over the background signal observed in uninfected mice (Dashed line). (E) Western blot
analysis of PVX-110940- in isolated exosomes (CD5L-highest SEC fraction) derived from plasma of P. vivax infected FRG huHep mice from EI1 and EI2. Hundred
micro liters of CD5L-highest fraction were blotted. Membranes were incubated with 1/50 of polyclonal anti-PVX110940 antibody. *Samples where a positive signal at
the expected molecular size (84 kDa) is observed.
P. falciparum development in liver cells (Meireles et al., 2017).
In addition, this enzyme also regulates the nitric oxide (NO)
concentration in some cells due to its competition for arginine
with the nitric oxide synthase, modulating in this way the
synthesis of the key immunomodulatory molecule, NO (Munder,
2009). The identification and validation of arginase I in ExEFs
from uninfected and infected mice indicates that this protein
could be a candidate liver-specific exosomal marker in this
model.
Our group and others have already identified Plasmodium
spp proteins associated with microvesicles and exosomes by
proteomic approaches (Mantel et al., 2013; Martín-Jaular et al.,
2016). In both cases, EVs have been obtained from culture
supernatant of infected P. falciparum and P. yoelii infected RBCs,
respectively. Both proteomes show the presence of proteins
exposed in the RBC membrane, proteins involved in the
invasion process and some metabolic enzymes. Another recent
study, found that microparticles isolated from the plasma of
malaria patients contain parasite proteins including cytoskeleton
components, enzymes, surface exposed and heat shock proteins
(Antwi-Baffour et al., 2016). The proteins associated with plasma-
derived exosomes from P. vivax infected FRG KO huHep mice
showed low coincidence with those previous reports, probably
reflecting the different cell types from which they originate.
Only, HSP70, a classical EV marker in all organisms studied
so far (Simpson et al., 2009), was found to be common to
all malaria EV proteomes until now published, pointing out a
selective-sorting mechanism of EVs and/or exosome secretion
in Plasmodium parasites. The validation of the hypothetical
conserved protein PVX_110940 in exosomal fractions of P. vivax
infected FRG huHep mice (Figure 6), indicates that, in principle,
the parasite proteins identified by mass spectrometry could be
detected by immunodetection techniques. This is of particular
interest in light of the feasibility of detecting hypnozoite specific
proteins associated to plasma-derived exosomes. The fact that
we identified three proteins uniquely present in ExEFs isolated
from FRG huHep plasma samples, after 16 and 21 days of
P. vivax infection, suggests that these proteins could originate
from hypnozoite-infected hepatocytes. Whether these proteins
are potential biomarkers of hypnozoite infection is currently
under investigation.
In summary, we have demonstrated that the P. vivax infected
FRG huHep liver chimeric mouse is a unique system for
the proteomic profiling of exosomes derived from human
infected hepatocytes secreted into the bloodstream. Moreover,
our work represents a proof-of-principle that parasite proteins
associated with plasma-derived exosomes can be identified by
mass-spectrometry in this model, opening the path toward the
discovery of hypnozoite biomarkers. Lastly, the identification of
human hepatocyte-specific surface biomarkers should facilitate
immunocapturing and detection of exosomes in plasma from
truly relapsing patients.
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Figure S1 | Experimental P. vivax infection of FRG huHep mice. (A) Six FRG
huHep mice were infected with 1 million P. vivax sporozoites. Infected mice were
euthanized 8 days post-infection (dpi) and blood samples collected. Four
uninfected control mice were also euthanized and blood samples collected. (B)
Twelve FRG huHep mice were infected with P. vivax sporozoites and euthanized 8
dpi (four mice), 10 dpi (four mice), 16 dpi (three mice), and 21 dpi (one mouse).
After plasma was collected from individual mice, plasma samples from two mice
were pooled to generate 2 plasma samples 8 dpi, 2 samples 10 dpi, and 2
samples 16 dpi (1 sample pooled from 2 mice and 1 sample from a single mouse).
Figure S2 | Molecular characterization of SEC fractions was done through flow
cytometry bead-based analysis of the CD5L marker. (A) Experimental infection 1
(EI1). Isolation of exosomes from the plasma of P. vivax infected FRG HuHep mice
was performed 8 days post infection (dpi). There were 6 infected mice (M1-M6)
and 4 uninfected mice (M1-M4). (B) Experimental infection 2 (EI2). Isolation of
exosomes from plasma of P. vivax infected FRG HuHep mice at 8 (2 mice:
M1-M2), 10 (2 mice: M1-M2), 16 (2 mice: M1-M2), and 21 (1 mouse) dpi. Images
show that CD5L-positive-exosomes were enriched in fractions 7−10. Based on
this profile, an exosomal enriched fraction (ExEF) and a plasma-microvesicles
enriched fraction (MvEF) were made by pooling fractions F7-F8-F9-F10 (black
dashed square) and fractions F5-F6-F11-F12 (red dashed square), respectively.
Blue circles: CD5L signal, Purple squares: negative control
(Fractions+rabbit-isotype+Alexa488-2a antibody, Black diamonds: Protein
concentration.
Data Sheet S1 | Characterization of P. vivax infection in liver tissue from FRG
huHep infected mice.
Data Sheet S2 | Mass spectrometry data of H. sapiens, Mus musculus and P.
vivax proteins identified in ExEFs.
Data Sheet S3 | Statistical analysis of H. sapiens proteins identified in the ExEFs
and MvEFs and in the ExEFs of infected and uninfected mice from Experimental
infection 1.
Data Sheet S4 | Gene ontology enrichment analysis of H. sapiens proteins
identified in the ExEFs of FRG huHep P. vivax infected mice.
Data Sheet S5 | Global comparison of H. sapiens proteins identified in the ExEFs
of P. vivax infected FRG huHep mice with the core proteins identified in the
previously published proteomes of hepatocytes-derived exosomes.
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